# REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects

> **NCT03618095** · NA · TERMINATED · sponsor: **Boston Scientific Corporation** · enrollment: 382 (actual)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DEVICE:** LOTUS Edge Valve System

## Key facts

- **NCT ID:** NCT03618095
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-01-14
- **Primary completion:** 2021-03-30
- **Final completion:** 2021-03-31
- **Target enrollment:** 382 (ACTUAL)
- **Why stopped:** Investigational Medical Device is no longer available
- **Last updated:** 2022-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03618095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03618095, "REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03618095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*